Dry Age-Related Macular Degeneration (Dry AMD) is a common eye condition that gradually damages the macula, the part of your retina responsible for sharp, central vision. Over time, Dry AMD can make everyday tasks like reading or recognizing faces more difficult. Until recently, there were few options to slow its progression.
We’re proud to offer the Valeda Light Delivery System, the first FDA-authorized treatment specifically designed for patients with Dry AMD.
Valeda uses photobiomodulation, a gentle light-based therapy that delivers specific wavelengths of light—blue, red, and near-infrared—to your retina. These wavelengths stimulate the energy centers of your cells, called mitochondria, to promote cell repair, reduce inflammation, and support better eye health.
